Clinical Trials Logo

Clinical Trial Summary

Due to widespread use of cross-sectional imaging modalities, pancreatic cysts are common in abdominal image. These lesions encompass a wide spectrum, ranging from benign to malignant. The diagnosing specific type of cystic lesion is limited in spite of recent advances of diagnostic modalities. Surgical resection is generally recommended for malignant and potentially malignant lesions. However, surgical resection has significant morbidity and sometimes mortality. Recently, a few study of EUS-guided ethanol lavage for cystic tumors of the pancreas reported that complete resolution was achieved in only one-third of patients. Ethanol lavage of pancreatic cysts may be alternative method to surgical resection.

The purpose of this study is the double ethanol lavage is a safe and effective method for treatment in those with the indeterminate pancreas cysts.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02213419
Study type Interventional
Source Samsung Medical Center
Contact Jong-Kyun Lee, M.D., Ph.D.
Phone 82-2-3410-3407
Email jongk.lee@samsung.com
Status Recruiting
Phase Phase 1
Start date October 2014
Completion date August 2016

See also
  Status Clinical Trial Phase
Completed NCT03188991 - Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms Phase 2
Recruiting NCT02110498 - Early Detection of Pancreatic Cystic Neoplasms
Terminated NCT02494388 - Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions N/A